Publications
151
Citations
3,317
Est. group size
~11
Recurring co-author estimate
Active years
23
Publishing since 2004
Typically publishes in teams of ~15 · 13% small-team papers (≤3 authors) · across 12 venues
- Abstract A073: Identification of a potential intermediate cell state in the treatment-induced lineage transition from AR-driven prostate cancer to neuroendocrine prostate cancer
Cancer Research · 2026
- Abstract B022: LuCaP189.4_CL: a novel 2D model of <i>AR</i> <b>-</b> high, <i>CDK12</i> <b>-</b> mutant mCRPC suitable for studies of genetic and therapeutic vulnerabilities
Cancer Research · 2026
- Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategies
eLife · 2025
- Multiomic assessments of LNCaP and derived cell strains reveal determinants of prostate cancer pathobiology
Journal of Clinical Investigation · 2025
- Author response: Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategies
2025
- CHIMERA-DDR: A Machine Learning Framework for Classifying Heterogeneous Mismatch-Repair and Homologous-Recombination Deficiency Patterns in Prostate Cancer
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategies
eLife · 2024
- P104 Upregulation of both APRIL and BAFF in systemic lupus erythematosus suggests non-redundant roles, further revealed by potent dual inhibition with povetacicept (TACI vTD-Fc; ALPN-303)
Poster presentations · 2024
- Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategies
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Identification and characterization of prognostic isoforms associated with bladder cancer outcomes.
Journal of Clinical Oncology · 2024
- Abstract C033: Identifying and targeting prostate cancer therapy resistance mechanisms driven by the tumor microenvironment
Cancer Research · 2024
- Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategies
eLife · 2024
- Peripheral T-cell receptor repertoire dynamics in small cell lung cancer
Translational Lung Cancer Research · 2023
- Povetacicept (ALPN-303), a Potent Dual BAFF/APRIL Antagonist in Development for the Treatment of Autoimmune Cytopenias, Suppresses Disease in a Mouse Model of Autoimmune Hemolytic Anemia
Blood · 2023
- Mechanisms of Severe Acute Respiratory Syndrome Coronavirus-Induced Acute Lung Injury
UNC Libraries · 2020
- Cancer Research×9
- Figshare×8
- UNC Libraries×4
- Clinical Cancer Research×3
- eLife×3
- Joel A. Yates
Medicine · University of Michigan
- William K. Storck
Medicine · University of Michigan
- Eva S. Rodansky
Medicine · University of Michigan
- Anbarasu Kumaraswamy
Medicine · University of Michigan
- Abhijit Parolia
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile